KHẢO SÁT TÌNH HÌNH SỬ DỤNG THUỐC ĐIỀU TRỊ THIẾU MÁU TRÊN BỆNH NHÂN BỆNH THẬN MẠN GIAI ĐOẠN CUỐI ĐANG LỌC MÁU CHU KỲ TẠI BỆNH VIỆN ĐA KHOA LONG AN

Abstract

Objective: To investigate the characteristics of drug treatments for anemia and their effectiveness in patients with peiodic hemodialysis during a period of 6 months. Materials and methods: A descriptive cross-sectional study was conducted on patients with end-stage chronic renal failure undergoing dialysis and were being treated with anemia medications at the Renal dialysis Unit of Long An General Hospital between 1/1-31/12/2020. Result: Of 111 patients, 44.4% were male and the mean age was 55.9±1.5 years. All patients received intravenous erythropoietin stimulating agents (ESA) at a common dose of 6000 IU/week and 13.2% of cases were combined with oral iron. A percentage of 29.7% of patients reached the target Hgb level from 10 to 11.5 g/dL. Patients with target RBC and Hct levels accounted for 9.9% and 12.6%, respectively. Conclusion: Anemia treatment for end-stage renal disease patients udergoing peiodic hemodialysis were still not optimal.